title: Drug marketing exclusivity under United States and European Union law.
authors.affiliation: Junod, Guyet, Muhlstein & Lévy, Switzerland.
authors.forename: Valerie
authors.initials: V
authors.lastname: Junod
mesh_terms: D001702:Biopharmaceutics / Q000191:economics / Q000331:legislation & jurisprudence; D002986:Clinical Trials as Topic; D003132:Commerce / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic / Q000191:economics; D004465:Economic Competition / Q000331:legislation & jurisprudence*; D005062:European Union; D006801:Humans; D017387:Investigational New Drug Application / Q000191:economics / Q000331:legislation & jurisprudence; D007880:Legislation, Drug; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D004366:Nonprescription Drugs; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016568:Drugs, Generic; D004366:Nonprescription Drugs